We Think Prime Medicine (NASDAQ:PRME) Needs To Drive Business Growth Carefully

Simply Wall StDec 19 20:35

Express News | Prime Medicine Inc Files for Resale of up to 11 Mln Common Shares by the Selling Stockholder - SEC Filing

BreakingsDec 13 21:20

Prime Medicine Initiated at Market Outperform by JMP Securities

Dow JonesDec 11 00:34 · Ratings

JMP Securities Initiates Prime Medicine(PRME.US) With Buy Rating, Announces Target Price $10

Futu NewsDec 10 14:31 · Ratings

Prime Medicine, Inc.: Innovative Gene Editing Platform With Significant Market Potential

TipRanksDec 10 14:06

Guggenheim Reiterates Buy on Prime Medicine, Maintains $18 Price Target

BenzingaDec 4 00:44 · Ratings